zur Navigation zum Inhalt
Onkologie 14. April 2010

Austrian consensus recommendations for the treatment of patients with multiple myeloma

The treatment of multiple myeloma (MM) has undergone significant developments due to the incorporation of novel agents (thalidomide, bortezomib and lenalidomide), which has improved the clinical outcome of patients with MM. This review summarizes the most recent results and represents a treatment recommendation for MM patients in the routine clinical setting.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben